Building Research in Implementation and Dissemination to close Gaps and achieve Equity in Cancer Control (BRIDGE-C2) Administrative Supplement

在实施和传播方面开展研究，以缩小差距并实现癌症控制的公平性 (BRIDGE-C2) 行政补充文件

• 批准号: 10173282
• 负责人: Jennifer E DeVoe
• 金额: $ 16.42万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-19 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10173282
• 关键词: Address; Administrative Supplement; Adopted; Adoption; COVID-19; COVID-19 pandemic; Cancer Control; Caring; County; Data; Development; Disease Outbreaks; Electronic Health Record; Evidence based intervention; Funding; Future; Geography; Grant; Guidelines; Health Sciences; Healthcare; Infrastructure; Institutes; Interview; Investigation; Laboratories; Malignant Neoplasms; Methods; Monitor; Neighborhood Health Center; Office Visits; Oregon; Patients; Persons; Positioning Attribute; Prevention; Prevention Guidelines; Preventive Intervention; Preventive care; Primary Health Care; Process; Recommendation; Research; Research Personnel; Screening for cancer; Structure; Telephone; Time; Variant; Visit; Vulnerable Populations; Work; cancer prevention; care delivery; evidence base; health care delivery; health disparity; implementation science; implementation strategy; improved; innovation; insight; interest; member; multidisciplinary; operation; pandemic disease; parent grant; practice-based research network; primary care setting; programs; response; training opportunity

This supplement will explore how the COVID-19 pandemic is impacting cancer screening and prevention (i.e., cancer preventive care) among patients receiving care in community health centers (CHCs) by leveraging the The Building Research in Implementation and Dissemination to close Gaps and achieve Equity in Cancer Control (BRIDGE-C2 ) Center Implementation Laboratory infrastructure. CHCs adapted and changed the way they deliver care during the current pandemic. For example, our Laboratory CHCs showed an 80% decline of in-person office visits, March to April 2020, in which cancer preventive care is typically delivered. This supplement will allow our team to collect the data needed to inform and align the research of our BRIDGE-C2 Center Parent Grant with the new realities of providing healthcare during the COVID-19 pandemic. We will track and understand the implementation strategies made by CHCs to change healthcare delivery processes and priorities, especially cancer preventive care, and share these critical lessons with a variety of stakeholders including the Implementation Science Centers in Cancer Control Program (ISC3 ) and CHCs across the US. With this supplement we will extend the work of our Parent Grant to answer the following questions: (1) What impact has COVID-19 had on the delivery of cancer preventive care; (2) What are the within and across state variations in CHC response to local levels of the COVID-19 outbreak and state / county actions; (3) What processes did CHCs use to adapt existing or adopt new strategies and implement operational changes to realign care with cancer preventive care guidelines in the COVID-19 context; and, (4) How do these findings inform BRIDGE-C2 Center’s future work? Once answered, more questions will become apparent leading to larger scale investigations and additional requests for grant funding. The BRIDGE-C2 Center with its national Implementation Laboratory of geographically diverse CHCs caring for over 1.9 million patients impacted by health disparities is uniquely positioned to extend its Parent Grant to quickly answer these important questions. The Aims of this supplement are: Aim 1: Identify and monitor the impact of the COVID-19 pandemic on delivery and receipt of cancer preventive care over a 12-month period; Aim 2: Identify the processes CHCs used, the external support and assistance they received to implement and adapt cancer preventive care to the COVID19 pandemic context, and operational changes employed to realign care with cancer prevention guidelines; and, Aim 3: Rapidly disseminate findings to a variety of relevant stakeholders. This supplemental work will: (1) advance implementation science by understanding how local adaptations were rapidly implemented or deimplemented in a crisis; (2) guide cancer prevention recommendations on identifying new or adapted ways to deliver cancer preventive care; and (3) rapidly distill and widely disseminate critical implementation findings to NCI laboratories and centers, CHCs and other primary care settings.

本增刊将探讨COVID-19大流行如何影响癌症筛查和预防（即，通过利用实施和传播中的建筑研究来缩小差距并实现癌症控制（BRIDGE-C2）中心实施实验室基础设施的公平性，在社区卫生中心（CHC）接受护理的患者中开展癌症预防护理。社区卫生中心在当前的大流行期间调整和改变了提供护理的方式。例如，我们的实验室CHC显示，2020年3月至4月，亲自到办公室就诊的人数下降了80%，其中通常提供癌症预防护理。这一补充将使我们的团队能够收集所需的数据，为我们的BRIDGE-C2中心父母补助金的研究提供信息，并使其与COVID-19大流行期间提供医疗保健的新现实保持一致。我们将跟踪和了解CHCs制定的实施策略，以改变医疗保健提供流程和优先事项，特别是癌症预防护理，并与各种利益相关者分享这些关键经验教训，包括癌症控制计划实施科学中心（ISC 3）和美国各地的CHCs。有了这个补充，我们将扩展我们的父母补助金的工作，以回答以下问题：（1）COVID-19对癌症预防护理的提供有什么影响;（2）CHC对COVID-19爆发和州/县行动的地方水平的反应在州内和州际之间有什么变化;（3）社区卫生中心采用了哪些流程来调整现有或采用新的策略，并实施运营变革，以在COVID-19背景下重新调整护理与癌症预防护理指南;以及（4）这些发现如何指导BRIDGE-C2中心未来的工作？一旦得到解答，更多的问题将变得明显，从而导致更大规模的调查和额外的拨款请求。BRIDGE-C2中心及其国家实施实验室的地理位置不同的CHCs照顾超过190万受健康差异影响的患者，具有独特的优势，可以扩展其父母补助金，以快速回答这些重要问题。本补充文件的目的是：目的1：识别和监测COVID-19大流行对12个月期间癌症预防护理的提供和接受的影响;目的2：识别社区卫生中心使用的流程，他们在实施和调整癌症预防护理以适应COVID-19大流行的情况下获得的外部支持和援助，以及为使护理与癌症预防指南保持一致而进行的操作变更;目标3：迅速向各种利益攸关方传播调查结果。这项补充工作将：（1）通过了解当地适应如何在危机中迅速实施或取消，推进实施科学;（2）指导癌症预防建议，确定新的或适应的方法来提供癌症预防护理;（3）快速提取并广泛传播关键实施结果，以NCI实验室和中心，CHC和其他初级保健环境。